Beyond ductal closure: interpreting the TREOCAPA trial in the evolving management of patent ductus arteriosus in preterm infants
Aimann Surak, Willem P de Boode · 2026
Read Beyond ductal closure: interpreting the TREOCAPA trial in the evolving management of patent ductus arteriosus in preterm infants by Aimann Surak, Willem P de Boode (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13655855.txt.
Description
Closing a heart duct in early-born babies is easy to do, yet whether it helps them thrive has stayed in doubt for decades. Aimann Surak and Willem de Boode weigh a fresh trial of early drug closure in work from twenty twenty-six. The trial gave a common pain drug by vein in the first half day of life to near eight hundred tiny babies.
Closure by one week rose, and rescue care fell, in the drug group. Yet survival free of grave ills at the set age did not improve. The gap between duct shape and true outcomes is the core of the piece. The authors read the trial as a call to ask sharper questions: who, if anyone, gains from closure at all.
Catalog record
| CREATOR | Aimann Surak, Willem P de Boode |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |